{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:39:11Z","timestamp":1759941551902,"version":"3.41.2"},"reference-count":60,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.25122\/jml-2024-0359","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:49:19Z","timestamp":1752076159000},"page":"171-178","source":"Crossref","is-referenced-by-count":1,"title":["Challenges of concurrent HIV infection in the course and management of Crohn\u2019s disease"],"prefix":"10.25122","volume":"18","author":[{"given":"Husna Irfan","family":"Thalib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamyaa","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Alnuwaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanin","family":"Alsaadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda Ahmed","family":"Allouji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jena","family":"Alyafei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layan","family":"Alshowiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuran","family":"Alsobyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma El Sayed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Medical Physiology Department, Kasr Alainy Faculty of Medicine, Cairo University, Giza, Egypt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Physiology, Batterjee Medical College, Jeddah, Saudi Arabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","reference":[{"issue":"6","key":"ref1","doi-asserted-by":"publisher","first-page":"e41120","DOI":"10.7759\/cureus.41120","article-title":"Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation","volume":"15","author":"Muzammil MA, Fariha F, Patel T, Sohail R, Kumar M, Khan E","year":"2023","unstructured":"1. Muzammil MA, Fariha F, Patel T, Sohail R, Kumar M, Khan E, Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation, Cureus, 2023;15(6):e41120","journal-title":"Cureus"},{"issue":"1","key":"ref2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G","year":"2012","unstructured":"2. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 2012;142(1):46-54.e42quiz e30","journal-title":"Gastroenterology"},{"issue":"2","key":"ref3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.gastro.2020.05.060","article-title":"AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders","volume":"159","author":"Preidis GA, Weizman AV, Kashyap PC, Morgan RL","year":"2020","unstructured":"3. Preidis GA, Weizman AV, Kashyap PC, Morgan RL, AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders, Gastroenterology, 2020;159(2):708-738.e4","journal-title":"Gastroenterology"},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.DMIH2-0026-2016","article-title":"Overview of Infections in the Immunocompromised Host","volume":"4","author":"Dropulic LK, Lederman HM","year":"2016","unstructured":"4. Dropulic LK, Lederman HM, Overview of Infections in the Immunocompromised Host, Microbiol Spectr, 2016;4(4):doi: 10.1128\/microbiolspec.DMIH2-0026-2016","journal-title":"Microbiol Spectr"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"20220821","DOI":"10.1515\/biol-2022-0821","article-title":"Probiotics for inflammatory bowel disease: Is there sufficient evidence?","volume":"19","author":"Ma Y, Yang D, Huang J, Liu K, Liu H, Wu H, Bao C","year":"2024","unstructured":"5. Ma Y, Yang D, Huang J, Liu K, Liu H, Wu H, Bao C, Probiotics for inflammatory bowel disease: Is there sufficient evidence?, Open Life Sci, 2024;19(1):20220821","journal-title":"Open Life Sci"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/imr.12902","article-title":"NOD1 and NOD2 in inflammatory and infectious diseases","volume":"297","author":"Trindade BC, Chen GY","year":"2020","unstructured":"6. Trindade BC, Chen GY, NOD1 and NOD2 in inflammatory and infectious diseases, Immunol Rev, 2020;297(1):139-161","journal-title":"Immunol Rev"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcmgh.2018.10.009","article-title":"NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis","volume":"7","author":"Ferrand A, Al Nabhani Z, Tapias NS, Mas E, Hugot JP, Barreau F","year":"2019","unstructured":"7. Ferrand A, Al Nabhani Z, Tapias NS, Mas E, Hugot JP, Barreau F, NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis, Cell Mol Gastroenterol Hepatol, 2019;7(2):357-369","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"34","key":"ref8","doi-asserted-by":"publisher","first-page":"12102","DOI":"10.3748\/wjg.v20.i34.12102","article-title":"Infectious etiopathogenesis of Crohn's disease","volume":"20","author":"Carri\u00e8re J, Darfeuille-Michaud A, Nguyen HT","year":"2014","unstructured":"8. Carri\u00e8re J, Darfeuille-Michaud A, Nguyen HT, Infectious etiopathogenesis of Crohn's disease, World J Gastroenterol, 2014;20(34):12102-17","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Odenwald MA, Turner JR","year":"2017","unstructured":"9. Odenwald MA, Turner JR, The intestinal epithelial barrier: a therapeutic target?, Nat Rev Gastroenterol Hepatol, 2017;14(1):9-21","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","article-title":"Intestinal barrier in inflammatory bowel disease","volume":"20","author":"Antoni L, Nuding S, Wehkamp J, Stange EF","year":"2014","unstructured":"10. Antoni L, Nuding S, Wehkamp J, Stange EF, Intestinal barrier in inflammatory bowel disease, World J Gastroenterol, 2014;20(5):1165-79","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/CEG.S53381","article-title":"Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets","volume":"9","author":"Manuc TE, Manuc MM, Diculescu MM","year":"2016","unstructured":"11. Manuc TE, Manuc MM, Diculescu MM, Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets, Clin Exp Gastroenterol, 2016;959-70","journal-title":"Clin Exp Gastroenterol"},{"issue":"5","key":"ref12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ibd.21171","article-title":"The path to Crohn's disease: is mucosal pathology a secondary event?","volume":"16","author":"Behr MA","year":"2010","unstructured":"12. Behr MA, The path to Crohn's disease: is mucosal pathology a secondary event?, Inflamm Bowel Dis, 2010;16(5):896-902","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00535-009-0138-3","article-title":"Evolving paradigms in the pathogenesis of IBD","volume":"45","author":"Mayer L","year":"2010","unstructured":"13. Mayer L, Evolving paradigms in the pathogenesis of IBD, J Gastroenterol, 2010;45(1):9-16","journal-title":"J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3389\/fimmu.2015.00489","article-title":"Intestinal Microbiota and the Innate Immune System-A Crosstalk in Crohn's Disease Pathogenesis","volume":"6","author":"Haag LM, Siegmund B","year":"2015","unstructured":"14. Haag LM, Siegmund B, Intestinal Microbiota and the Innate Immune System-A Crosstalk in Crohn's Disease Pathogenesis, Front Immunol, 2015;6489","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3389\/fimmu.2017.00942","article-title":"Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease","volume":"8","author":"Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z","year":"2017","unstructured":"15. Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z, Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease, Front Immunol, 2017;8942","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1756284820935188","DOI":"10.1177\/1756284820935188","article-title":"Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies","volume":"13","author":"Chen H, Li H, Liu Z","year":"2020","unstructured":"16. Chen H, Li H, Liu Z, Interplay of intestinal microbiota and mucosal immunity in inflammatory bowel disease: a relationship of frenemies, Therap Adv Gastroenterol, 2020;131756284820935188","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13099-022-00521-0","article-title":"Gut microbiota in the early stage of Crohn's disease has unique characteristics","volume":"14","author":"Ma X, Lu X, Zhang W, Yang L, Wang D, Xu J","year":"2022","unstructured":"17. Ma X, Lu X, Zhang W, Yang L, Wang D, Xu J, Gut microbiota in the early stage of Crohn's disease has unique characteristics, Gut Pathog, 2022;14(1):46","journal-title":"Gut Pathog"},{"issue":"4","key":"ref18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","article-title":"Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics","volume":"11","author":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M","year":"2017","unstructured":"18. Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M, Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics, ISME J, 2017;11(4):841-852","journal-title":"ISME J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fmicb.2016.00925","article-title":"Bifidobacteria and Their Role as Members of the Human Gut Microbiota","volume":"7","author":"O'Callaghan A, van Sinderen D","year":"2016","unstructured":"19. O'Callaghan A, van Sinderen D, Bifidobacteria and Their Role as Members of the Human Gut Microbiota, Front Microbiol, 2016;7925","journal-title":"Front Microbiol"},{"issue":"6","key":"ref20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2017.10.001","article-title":"Action and function of Akkermansia muciniphila in microbiome ecology, health and disease","volume":"31","author":"Ottman N, Geerlings SY, Aalvink S, de Vos WM, Belzer C","year":"2017","unstructured":"20. Ottman N, Geerlings SY, Aalvink S, de Vos WM, Belzer C, Action and function of Akkermansia muciniphila in microbiome ecology, health and disease, Best Pract Res Clin Gastroenterol, 2017;31(6):637-642","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1098386","DOI":"10.3389\/fmicb.2023.1098386","article-title":"Role of gut microbiota in infectious and inflammatory diseases","volume":"14","author":"Maciel-Fiuza MF, Muller GC, Campos DMS, do Socorro Silva Costa P, Peruzzo J, Bonamigo RR","year":"2023","unstructured":"21. Maciel-Fiuza MF, Muller GC, Campos DMS, do Socorro Silva Costa P, Peruzzo J, Bonamigo RR, Role of gut microbiota in infectious and inflammatory diseases, Front Microbiol, 2023;141098386","journal-title":"Front Microbiol"},{"issue":"10","key":"ref22","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.3390\/ijms21103734","article-title":"Adherent-Invasive E. coli Update on the Lifestyle of a Troublemaker in Crohn's Disease","volume":"21","author":"Chervy M, Barnich N, Denizot J","year":"2020","unstructured":"22. Chervy M, Barnich N, Denizot J, Adherent-Invasive E. coli Update on the Lifestyle of a Troublemaker in Crohn's Disease, Int J Mol Sci, 2020;21(10):3734","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mib.2014.11.013","article-title":"Fusobacterium nucleatum: a commensal-turned pathogen","volume":"23","author":"Han YW","year":"2015","unstructured":"23. Han YW, Fusobacterium nucleatum: a commensal-turned pathogen, Curr Opin Microbiol, 2015;23141-7","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C","year":"2022","unstructured":"24. Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Microbiota in health and diseases, Signal Transduct Target Ther, 2022;7(1):135","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"ref25","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/ijms23073464","article-title":"Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets","volume":"23","author":"Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP","year":"2022","unstructured":"25. Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP, Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets, Int J Mol Sci, 2022;23(7):3464","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref26","first-page":"759","article-title":"The therapeutic effect of probiotic bacteria on gastrointestinal diseases","volume":"22","author":"Sarowska J, Choroszy-Kr\u00f3l I, Regulska-Ilow B, Frej-M\u0105drzak M, Jama-Kmiecik A","year":"2013","unstructured":"26. Sarowska J, Choroszy-Kr\u00f3l I, Regulska-Ilow B, Frej-M\u0105drzak M, Jama-Kmiecik A, The therapeutic effect of probiotic bacteria on gastrointestinal diseases, Adv Clin Exp Med, 2013;22(5):759-66","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","article-title":"Pathophysiology of Crohn's disease inflammation and recurrence","volume":"15","author":"Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A","year":"2020","unstructured":"27. Petagna L, Antonelli A, Ganini C, Bellato V, Campanelli M, Divizia A, Pathophysiology of Crohn's disease inflammation and recurrence, Biol Direct, 2020;15(1):23","journal-title":"Biol Direct"},{"issue":"10","key":"ref28","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cells12101351","article-title":"HIV-Host Cell Interactions","volume":"12","author":"Masenga SK, Mweene BC, Luwaya E, Muchaili L, Chona M, Kirabo A","year":"2023","unstructured":"28. Masenga SK, Mweene BC, Luwaya E, Muchaili L, Chona M, Kirabo A, HIV-Host Cell Interactions, Cells, 2023;12(10):1351","journal-title":"Cells"},{"issue":"5(193)","key":"ref29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006438","article-title":"Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism","volume":"10","author":"Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ","year":"2013","unstructured":"29. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism, Sci Transl Med, 2013;10(5(193)):193ra91 Erratum in: Sci Transl Med. 2017 Nov 8;9(415):eaar3209 doi: 10.1126\/scitranslmed.aar3209","journal-title":"Sci Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1020822","DOI":"10.3389\/fimmu.2022.1020822","article-title":". The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection","volume":"13","author":"Zhang Y, Xie Z, Zhou J, Li Y, Ning C, Su Q","year":"2023","unstructured":"30. Zhang Y, Xie Z, Zhou J, Li Y, Ning C, Su Q, . The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection, Front Immunol, 2023;131020822","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3080969","DOI":"10.1155\/2023\/3080969","article-title":"Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients","volume":"2023","author":"Pan Z, Wu N, Jin C","year":"2023","unstructured":"31. Pan Z, Wu N, Jin C, Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients, Can J Infect Dis Med Microbiol, 2023;20233080969","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"ref32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cgh.2020.12.023","article-title":"Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study","volume":"20","author":"Guillo L, Uzzan M, Beaugerie L, Gornet JM, Amiot A, Pelletier AL","year":"2022","unstructured":"32. Guillo L, Uzzan M, Beaugerie L, Gornet JM, Amiot A, Pelletier AL, Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study, Clin Gastroenterol Hepatol, 2022;20(4):787-797.e2","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"ref33","doi-asserted-by":"publisher","first-page":"e8351","DOI":"10.7759\/cureus.8351","article-title":"Medical Management of Crohn's Disease","volume":"12","author":"Gade AK, Douthit NT, Townsley E","year":"2020","unstructured":"33. Gade AK, Douthit NT, Townsley E, Medical Management of Crohn's Disease, Cureus, 2020;12(5):e8351","journal-title":"Cureus"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/nu10050537","article-title":"Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease","volume":"10","author":"Hansen T, Duerksen DR","year":"2018","unstructured":"34. Hansen T, Duerksen DR, Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease, Nutrients, 2018;10(5):537","journal-title":"Nutrients"},{"issue":"8","key":"ref35","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1007\/s10620-015-3618-8","article-title":"Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability","volume":"60","author":"Shah ED, Siegel CA, Chong K, Melmed GY","year":"2015","unstructured":"35. Shah ED, Siegel CA, Chong K, Melmed GY, Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability, Dig Dis Sci, 2015;60(8):2408-18","journal-title":"Dig Dis Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.4103\/sjg.sjg_277_22","article-title":"Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease","volume":"29","author":"Mosli MH, Almudaiheem HY, AlAmeel T, Bakkari SA, Alharbi OR, Alenzi KA","year":"2022","unstructured":"36. Mosli MH, Almudaiheem HY, AlAmeel T, Bakkari SA, Alharbi OR, Alenzi KA, Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease, Saudi J Gastroenterol, 2022;29(Suppl 1):S1-S35","journal-title":"Saudi J Gastroenterol"},{"issue":"2","key":"ref37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1055\/s-0033-1348043","article-title":"Medical management of crohn disease","volume":"26","author":"Scott FI, Osterman MT","year":"2013","unstructured":"37. Scott FI, Osterman MT, Medical management of crohn disease, Clin Colon Rectal Surg, 2013;26(2):67-74","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"ref38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.suc.2023.12.005","article-title":"Medical Management of Inflammatory Bowel Disease","volume":"104","author":"Rahman S, Patel RK, Boden E, Tsikitis VL","year":"2024","unstructured":"38. Rahman S, Patel RK, Boden E, Tsikitis VL, Medical Management of Inflammatory Bowel Disease, Surg Clin North Am, 2024;104(3):657-671","journal-title":"Surg Clin North Am"},{"issue":"6","key":"ref39","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.14309\/ajg.0000000000001220","article-title":"Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis","volume":"116","author":"Targownik LE, Bernstein CN, Benchimol EI, Kaplan GG, Singh H, Tennakoon A","year":"2021","unstructured":"39. Targownik LE, Bernstein CN, Benchimol EI, Kaplan GG, Singh H, Tennakoon A, Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis, Am J Gastroenterol, 2021;116(6):1284-1293","journal-title":"Am J Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"481651","DOI":"10.5402\/2013\/481651","article-title":"Health benefits of probiotics: a review","volume":"2013","author":"Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N","year":"2013","unstructured":"40. Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, Health benefits of probiotics: a review, ISRN Nutr, 2013;2013481651","journal-title":"ISRN Nutr"},{"issue":"2","key":"ref41","first-page":"1009","article-title":"Effects of probiotics on inflammatory bowel disease: A systematic review","volume":"1","author":"Lopes G, Campanari GSDS, Barbalho SM, Matias JN, Lima VM, Ara\u00fajo AC","year":"2021","unstructured":"41. Lopes G, Campanari GSDS, Barbalho SM, Matias JN, Lima VM, Ara\u00fajo AC, Effects of probiotics on inflammatory bowel disease: A systematic review, Japanese J Gastroenterol Res, 2021;1(2):1009","journal-title":"Japanese J Gastroenterol Res"},{"issue":"1","key":"ref42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/09637486.2018.1477123","article-title":"Probiotics for inflammatory bowel diseases: a promising adjuvant treatment","volume":"70","author":"Coqueiro AY, Raizel R, Bonvini A, Tirapegui J, Rogero MM","year":"2019","unstructured":"42. Coqueiro AY, Raizel R, Bonvini A, Tirapegui J, Rogero MM, Probiotics for inflammatory bowel diseases: a promising adjuvant treatment, Int J Food Sci Nutr, 2019;70(1):20-29","journal-title":"Int J Food Sci Nutr"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-013-0440-8","article-title":"Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials","volume":"7","author":"Fujiya M, Ueno N, Kohgo Y","year":"2014","unstructured":"43. Fujiya M, Ueno N, Kohgo Y, Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials, Clin J Gastroenterol, 2014;7(1):1-13","journal-title":"Clin J Gastroenterol"},{"issue":"3","key":"ref44","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/jcp.25911","article-title":"Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review","volume":"233","author":"Ganji-Arjenaki M, Rafieian-Kopaei M","year":"2018","unstructured":"44. Ganji-Arjenaki M, Rafieian-Kopaei M, Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review, J Cell Physiol, 2018;233(3):2091-2103","journal-title":"J Cell Physiol"},{"issue":"5","key":"ref45","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3390\/nu11050969","article-title":"Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells","volume":"11","author":"Li SC, Hsu WF, Chang JS, Shih CK","year":"2019","unstructured":"45. Li SC, Hsu WF, Chang JS, Shih CK, Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells, Nutrients, 2019;11(5):969","journal-title":"Nutrients"},{"issue":"1","key":"ref46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4161\/derm.24494","article-title":"Sunlight and Vitamin D: A global perspective for health","volume":"5","author":"Wacker M, Holick MF","year":"2013","unstructured":"46. Wacker M, Holick MF, Sunlight and Vitamin D: A global perspective for health, Dermatoendocrinol, 2013;5(1):51-108","journal-title":"Dermatoendocrinol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1097\/MCG.0000000000000351","article-title":"Role of Probiotics in Crohn's Disease and in Pouchitis","volume":"49","author":"Guslandi M","year":"2015","unstructured":"47. Guslandi M, Role of Probiotics in Crohn's Disease and in Pouchitis, J Clin Gastroenterol, 2015;49(Suppl 1):S46-9","journal-title":"J Clin Gastroenterol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"572912","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as Major Disruptors of Gut Microbiota","volume":"10","author":"Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H","year":"2020","unstructured":"48. Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H, Antibiotics as Major Disruptors of Gut Microbiota, Front Cell Infect Microbiol, 2020;10572912","journal-title":"Front Cell Infect Microbiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/hiv.s7720","article-title":"Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions","volume":"2","author":"Castro JG, Morrison-Bryant M","year":"2010","unstructured":"49. Castro JG, Morrison-Bryant M, Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions, HIV AIDS (Auckl), 2010;2123-34","journal-title":"HIV AIDS (Auckl)"},{"issue":"2","key":"ref50","doi-asserted-by":"publisher","first-page":"G227","DOI":"10.1152\/ajpgi.00046.2020","article-title":"Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids","volume":"319","author":"Qian X, Yanagi K, Kane AV, Alden N, Lei M, Snydman DR, Vickers RJ, Lee K, Thorpe CM","year":"2020","unstructured":"50. Qian X, Yanagi K, Kane AV, Alden N, Lei M, Snydman DR, Vickers RJ, Lee K, Thorpe CM, Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids, Am J Physiol Gastrointest Liver Physiol, 2020;319(2):G227-G237","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"ref51","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MOG.0000000000000739","article-title":"Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease","volume":"37","author":"Dalal RS, Allegretti JR","year":"2021","unstructured":"51. Dalal RS, Allegretti JR, Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease, Curr Opin Gastroenterol, 2021;37(4):336-343","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"ref52","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41467-021-21472-1","article-title":"Fecal microbiota transplantation in HIV: A pilot placebo-controlled study","volume":"12","author":"Serrano-Villar S, Talavera-Rodr\u00edguez A, Gosalbes MJ, Madrid N, P\u00e9rez-Molina JA, Elliott RJ","year":"2021","unstructured":"52. Serrano-Villar S, Talavera-Rodr\u00edguez A, Gosalbes MJ, Madrid N, P\u00e9rez-Molina JA, Elliott RJ, Fecal microbiota transplantation in HIV: A pilot placebo-controlled study, Nat Commun, 2021;12(1):1139","journal-title":"Nat Commun"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"104113","DOI":"10.1016\/j.ebiom.2022.104113","article-title":"The gut virome: A new microbiome component in health and disease","volume":"81","author":"Cao Z, Sugimura N, Burgermeister E, Ebert MP, Zuo T, Lan P","year":"2022","unstructured":"53. Cao Z, Sugimura N, Burgermeister E, Ebert MP, Zuo T, Lan P, The gut virome: A new microbiome component in health and disease, EBioMedicine, 2022;81104113","journal-title":"EBioMedicine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1060581","DOI":"10.3389\/fmed.2022.1060581","article-title":"Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols","volume":"9","author":"Hamamah S, Gheorghita R, Lobiuc A, Sirbu IO, Covasa M","year":"2022","unstructured":"54. Hamamah S, Gheorghita R, Lobiuc A, Sirbu IO, Covasa M, Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols, Front Med (Lausanne), 2022;91060581","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"ref55","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3390\/biomedicines10061242","article-title":"Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease","volume":"10","author":"Yusuf K, Saha S, Umar S","year":"2022","unstructured":"55. Yusuf K, Saha S, Umar S, Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease, Biomedicines, 2022;10(6):1242","journal-title":"Biomedicines"},{"issue":"17","key":"ref56","doi-asserted-by":"publisher","first-page":"9588","DOI":"10.3390\/ijms23179588","article-title":"Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health","volume":"23","author":"Zhang P","year":"2022","unstructured":"56. Zhang P, Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health, Int J Mol Sci, 2022;23(17):9588","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/nu14010191","article-title":"The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets","volume":"14","author":"Attaye I, van Oppenraaij S, Warmbrunn MV, Nieuwdorp M","year":"2021","unstructured":"57. Attaye I, van Oppenraaij S, Warmbrunn MV, Nieuwdorp M, The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets, Nutrients, 2021;14(1):191","journal-title":"Nutrients"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"570520","DOI":"10.3389\/fphar.2021.570520","article-title":"Effects of Probiotics on Diarrhea and CD4 Cell Count in People Living With HIV: A Systematic Review and Meta-Analysis","volume":"12","author":"Zhang XL, Chen MH, Geng ST, Yu J, Kuang YQ, Luo HY","year":"2021","unstructured":"58. Zhang XL, Chen MH, Geng ST, Yu J, Kuang YQ, Luo HY, Effects of Probiotics on Diarrhea and CD4 Cell Count in People Living With HIV: A Systematic Review and Meta-Analysis, Front Pharmacol, 2021;12570520","journal-title":"Front Pharmacol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"7947342","DOI":"10.1155\/2020\/7947342","article-title":"The Effect of Probiotics, Prebiotics, and Synbiotics on CD4 Counts in HIV-Infected Patients: A Systematic Review and Meta-Analysis","volume":"2020","author":"Fu YS, Chu QS, Ashuro AA, Di DS, Zhang Q, Liu XM","year":"2020","unstructured":"59. Fu YS, Chu QS, Ashuro AA, Di DS, Zhang Q, Liu XM, The Effect of Probiotics, Prebiotics, and Synbiotics on CD4 Counts in HIV-Infected Patients: A Systematic Review and Meta-Analysis, Biomed Res Int, 2020;20207947342","journal-title":"Biomed Res Int"},{"issue":"5","key":"ref60","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/19390211.2017.1380103","article-title":"Effect of Probiotic Supplementation on CD4 Cell Count in HIV-Infected Patients: A Systematic Review and Meta-analysis","volume":"15","author":"Kazemi A, Djafarian K, Speakman JR, Sabour P, Soltani S, Shab-Bidar S","year":"2018","unstructured":"60. Kazemi A, Djafarian K, Speakman JR, Sabour P, Soltani S, Shab-Bidar S, Effect of Probiotic Supplementation on CD4 Cell Count in HIV-Infected Patients: A Systematic Review and Meta-analysis, J Diet Suppl, 2018;15(5):776-788","journal-title":"J Diet Suppl"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-3-2025\/review-issue-3-2025\/challenges-of-concurrent-hiv-infection-in-the-course-and-management-of-crohns-disease\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:49:25Z","timestamp":1752076165000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-3-2025\/review-issue-3-2025\/challenges-of-concurrent-hiv-infection-in-the-course-and-management-of-crohns-disease\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["JMedLife-18-171"],"URL":"https:\/\/doi.org\/10.25122\/jml-2024-0359","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}